Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medtronic CareLink Network begins to support Vision 3D implantable IDCs

Medtronic : 20 June, 2008  (New Product)
All Medtronic’s Vision 3D implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) are now compatible with the Medtronic CareLink Network.
More than 250,000 patients at 2,400 clinics in 20 countries currently are followed remotely via the Medtronic CareLink Network, which allows physicians to perform a complete analysis of all the device- and patient-specific cardiac data stored within Medtronic implantable cardiac devices. All current models of Medtronic ICDs, CRT-Ds and pacemakers are compatible with the Medtronic CareLink Network, which has registered more than one million patient data transmissions since its inception.

Medtronic offers the breadth of pacemaker and ICD therapies, deep and varied product lines, and geographic reach of the CareLink Network for remotely monitoring patients with Medtronic cardiac devices,” said Oern Stuge, president of Europe and Central Asia for Medtronic. “With the addition of Vision 3D devices on the Network, European physicians and patients can have increased confidence in the effectiveness of therapy delivery as well as wireless alerting capabilities for conditions such as worsening heart failure via CareAlert notifications.”

The Medtronic CareLink Network helps physicians and patients better manage chronic cardiovascular disease treated by implantable device therapy. The Network enables the transmission of patient and implanted device data using a portable monitor. Within minutes, the patient’s physician and nurses can view the data on a secure Internet web site.

For heart failure patients with Medtronic devices equipped with Conexus Wireless Telemetry all Vision 3D ICDs and CRT-Ds, as well as Concerto CRT-Ds or Virtuoso ICDs a Medtronic CareAlert Notification can be sent via the Medtronic CareLink Network to physicians wirelessly and automatically, providing timely insight into a patient’s changing disease condition and the potential for treatment decisions before the condition worsens.

The transmitted information, which is comparable to that provided during an in-clinic device follow-up visit, provides the physician with a view of how both the device and patient’s heart are operating.

The system provides an efficient, safe and convenient way for specialty physicians to remotely monitor the condition of their patients and, if needed, make adjustments to medication or prescribe additional therapy.

It also saves patients time by potentially eliminating some in-office visits.

Several pacemaker models have also been added for remote device data transmission via the Medtronic CareLink Network in the European market:

Adapta portfolio, including the Adapta, Versa and Sensia pacemakers;
EnRhythm pacemakers;
EnPulse pacemakers; and
Kappa 600, 700, 800, 900 pacemakers

The Adapta portfolio offers physicians and patients the convenience of automaticity, and Medtronic offers its remote monitoring service for its full range of current pacemakers in many countries around the world.

Data from the Medtronic-supported PREFER trial has been presented recently that showed remote monitoring of pacemaker patients via the Medtronic CareLink Network detected clinically actionable events (CAEs) more quickly than routine follow-up care of transtelephonic monitoring (TTM) and in-office visits.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo